BioStartup News Newsletter
Press Releases, Financial News,
Media Coverage, Careers and Events |
* - May need subscription or registration to view |
|
|
FOUNDATION PARTNER
|
|
|
|
|
PRESS RELEASES
|
|
|
- Cadrenal Therapeutics: Granted FDA Fast Track Designation for Tecarfarin for Prevention of Systemic Thromboembolism of Cardiac Origin in Patients With End-Stage Renal Disease and Atrial Fibrillation More
- Idera Pharmaceuticals: Name Change to Aceragen, Inc. and Provides Near-Term Strategic Outlook More
- IO Biotech: Appointment of Devin Smith as General Counsel More
- Known Medicine: BioTech Breakthrough Award for "Best Use of Artificial Intelligence in BioTech 2022" More
- Neumentum: Initiation of Phase 3 Program Evaluating Its Lead Product Candidate, NTM-001, for the Management of Moderately-Severe Acute Pain More
- Renibus Therapeutics: Oral Presentation on RBT-1 Phase 2 Results at 2023 Society of Critical Care Medicine (SCCM) Meeting More
- Tevogen Bio: Positive Proof-of-Concept Clinical Trial Results of Its Off-The-Shelf, Allogeneic Cytotoxic CD8+ T Cell Therapy for Treatment of Acute High-Risk COVID Patients, First Clinical Product of Company's Precision Cell Therapy Platform More
|
The Turnkey Alternative to Outsourcing your Science
Keep your in vivo studies in-house in Mispro’s full-service vivarium facilities. Our newest location in Boston’s Seaport.
Explore |
|
|
|
|
|
FINANCIAL NEWS
|
|
|
- Amgen Extends Autoimmune Pact With Small Michigan Biotech More More More More
- Digital Health Funding and Deals Roundup: Bayer Acquires AI Platform Company More
- Durham Biotech Developing Male Contraceptive Pill to Receive Up to $800,000 More
- Durham County Looks to Land Hundreds of Biotech Jobs With Economic Incentives More
- AccuStem Sciences: Genomic Oncology Test Developer Sets Terms for $11 Million Nasdaq Uplisting More
- GreenLab: Closes $5.2 Million Seed Round More
- Slate Bio Raises $1.75 Million in Quest to Commercialize U. of Va. Technology More*
- The Money Tree for Biotech Startups Loses Its Leaves Podcast
HOT INVESTOR MANDATES from JANUARY 5
- Hot Investor Mandate: Global Investment Firm Invests Up to $40M in Early Clinical Stage Therapeutics, Medical Devices, and Diagnostics Companies More
- Hot Investor Mandate: USA-Based Venture Capital Firm Invests in Early-Stage Therapeutics, Diagnostics, and Life Science Tools With Strong Intellectual Property More
- Hot Investor Mandate: Corporate Venture Arm of a Large Holding Company Invests in Novel Therapeutics and Medtech Technologies in CNS, Autoimmune Diseases, and More More
- Hot Investor Mandate: USA-Based VC Firm Allocates Up to $20M in Early-Stage Opportunities in Therapeutics and Therapeutic Medical Devices More
|
|
SECTION SPONSOR: |
|
|
|
|
|
MEDIA/MISC COVERAGE
|
|
|
- Blu Biotech Sniffing Out Infections, Cancer With Multi-Disease Breathalyzer More*
- From Professor to Innovator: How UNC Researcher Takes Lab Research to Startup More
- Hera Biotech Aims to Diagnose Endometriosis With Single-Cell Targeted Gene Expression Panel More*
- Increasing the Success Potential of Promising Biotech Companies More
- Most Recent Tweets From BioStartup News More
- No More Needles? That's a Promise of New Drug Delivery Tech From Chapel Hill Startup More
- Phoenix Biotech Firm ElectraTect Developing Technology for THC Breathalyzer More*
- Purdue Startup Named to Most Fundable List More
- Rockville Biotech RegenxBio Launches Clinical Trial in Muscular Dystrophy More*
- Roivant's Matt Gline on the Hub-and-Spoke Biotech Model and Lessons Learned From Axovant More
- Startup Aiming for FDA Clearance to Open 'Floodgates' on Heart Surgery Simulation Software More*
|
|
SECTION SPONSOR: |
|
|
|
|
|
COMPANIES
|
|
|
- US Life Science Startup Company Directory More
|
|
SECTION SPONSOR: |
|
|
|
|
|
EVENT CENTER
|
|
|
|
|
SECTION SPONSOR: |
|
|
|
DON'T MISS THE NEWS AND DEVELOPMENTS FROM THE "BIG 4" BIOTECH HUBS IN THE WORLD!
SUBSCRIBE NOW TO BIG4BIO'S DAILY NEWSLETTERS
|
|
|
|
CAREER CENTER
|
|
|
- Scientist, Targeted Proteomics, Kymera Therapeutics - Watertown, MA More
- Director, ADME-PK, Dyne Therapeutics - Waltham, MA More
- Clinical Trial Manager, Scipher Medicine -Waltham, MA, US / Onsite / Remote More
- Director, Medical Director, Day One Biopharmaceuticals - Remote / United States of America More
- Associate Director / Director, QC, Synthekine - Menlo Park, CA More
- Associate Scientist, Immunology, HotSpot Therapeutics - Boston, MA More
|
|
SECTION SPONSOR: |
|
|
|
|
|
SPONSORS
|
|
|
|
|
|